These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 29071385)
1. Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M. Li QQ; Hsu I; Sanford T; Railkar R; Balaji N; Sourbier C; Vocke C; Balaji KC; Agarwal PK Cell Mol Life Sci; 2018 Mar; 75(5):939-963. PubMed ID: 29071385 [TBL] [Abstract][Full Text] [Related]
2. A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo. Harikumar KB; Kunnumakkara AB; Ochi N; Tong Z; Deorukhkar A; Sung B; Kelland L; Jamieson S; Sutherland R; Raynham T; Charles M; Bagherzadeh A; Foxton C; Boakes A; Farooq M; Maru D; Diagaradjane P; Matsuo Y; Sinnett-Smith J; Gelovani J; Krishnan S; Aggarwal BB; Rozengurt E; Ireson CR; Guha S Mol Cancer Ther; 2010 May; 9(5):1136-46. PubMed ID: 20442301 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of protein kinase D2/Aurora kinase A signalling axis suppresses G2/M cell cycle progression and proliferation of epithelial ovarian cancer cells. Sachdeva A; Roy A; Gupta MK; Mandal S Pathol Res Pract; 2024 Aug; 260():155390. PubMed ID: 38878668 [TBL] [Abstract][Full Text] [Related]
4. The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells. Zhang R; Shi H; Ren F; Zhang M; Ji P; Wang W; Liu C J Ovarian Res; 2017 Sep; 10(1):60. PubMed ID: 28899430 [TBL] [Abstract][Full Text] [Related]
5. Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen-independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis. Zhang B; Lai Y; Li Y; Shu N; Wang Z; Wang Y; Li Y; Chen Z Eur J Pharmacol; 2018 Feb; 821():57-67. PubMed ID: 29277717 [TBL] [Abstract][Full Text] [Related]
6. SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest. Tandon M; Salamoun JM; Carder EJ; Farber E; Xu S; Deng F; Tang H; Wipf P; Wang QJ PLoS One; 2015; 10(3):e0119346. PubMed ID: 25747583 [TBL] [Abstract][Full Text] [Related]
7. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer. Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378 [TBL] [Abstract][Full Text] [Related]
8. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of protein kinase D suppresses epithelial ovarian cancer via MAPK/ERK1/2/Runx2 signalling axis. Tyagi K; Roy A; Mandal S Cell Signal; 2023 Oct; 110():110849. PubMed ID: 37562720 [TBL] [Abstract][Full Text] [Related]
10. Citrate-Induced p85α⁻PTEN Complex Formation Causes G Hung KC; Wang SG; Lin ML; Chen SS Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035650 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase d as a potential chemotherapeutic target for colorectal cancer. Wei N; Chu E; Wipf P; Schmitz JC Mol Cancer Ther; 2014 May; 13(5):1130-41. PubMed ID: 24634417 [TBL] [Abstract][Full Text] [Related]
12. Fisetin induces G2/M phase arrest and caspase-mediated cleavage of p21 Yadav M; Kandhari K; Mathan SV; Ali M; Singh RP Mol Carcinog; 2024 Sep; 63(9):1697-1711. PubMed ID: 38801393 [TBL] [Abstract][Full Text] [Related]
13. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo. Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449 [TBL] [Abstract][Full Text] [Related]
14. 4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathway. Chaudhary P; Sharma R; Sahu M; Vishwanatha JK; Awasthi S; Awasthi YC J Biol Chem; 2013 Jul; 288(28):20532-46. PubMed ID: 23733185 [TBL] [Abstract][Full Text] [Related]
15. Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. Tang Y; Simoneau AR; Xie J; Shahandeh B; Zi X Cancer Prev Res (Phila); 2008 Nov; 1(6):439-51. PubMed ID: 19138991 [TBL] [Abstract][Full Text] [Related]
16. Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells. Wang J; Chang L; Lai X; Li X; Wang Z; Huang Z; Huang J; Zhang G Cell Cycle; 2018; 17(6):671-680. PubMed ID: 29285984 [TBL] [Abstract][Full Text] [Related]
17. S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma. Khammanivong A; Wang C; Sorenson BS; Ross KF; Herzberg MC PLoS One; 2013; 8(7):e69395. PubMed ID: 23874958 [TBL] [Abstract][Full Text] [Related]
18. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
19. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells. Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578 [TBL] [Abstract][Full Text] [Related]
20. KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer. Anbalagan M; Carrier L; Glodowski S; Hangauer D; Shan B; Rowan BG Breast Cancer Res Treat; 2012 Apr; 132(2):391-409. PubMed ID: 21509526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]